Table 1.

Patient characteristics for men with Grade Group 2 prostate cancer

Numbers represent median (interquartile range) or frequency (percentage).

Characteristic	N=219
Age at Diagnosis, years	67 (61, 72)
Diagnostic PSA (ng/mL, N=201)	5 (4, 7)
Number of Positive Cores at Diagnosis (N=213)	2 (1, 3)
Number of Total Cores at Diagnosis (N=213)	12 (7, 14)
Nomogram Risk of Locally Advanced Disease (N=201)	50% (40%, 60%)
Total Cancer Length at Diagnosis (N=205), millimeters	4 (2, 6)
Year of Diagnosis
2000–2004	7 (3.2%)
2005–2009	31 (14%)
2010–2014	113 (52%)
2015–2017	68 (31%)
Clinical T Stage
≤T1C	151 (69%)
T2A	31 (14%)
T2B	5 (2.3%)
T2C	3 (1.4%)
T3A	2 (0.9%)
Unknown	27 (12%)
Charlson Comorbidity Index
0	158 (72%)
1	26 (12%)
2	26 (12%)
≥3	9 (4.1%)